The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer.

Thomas Bartl Christine Bekos Magdalena Postl Reinthaller Alexander Stephan Polterauer Stefanie Aust Schwameis Richard

Published in: Journal of gynecologic oncology (2020)

Pretherapeutic SII may serve as a promising predictor for survival in patients with vulvar cancer. After clinical validation, the SII may be used to improve both pre-treatment patient risk stratification and patient counseling.

Keyphrases

papillary thyroid
case report
squamous cell
sentinel lymph node
radiation therapy
childhood cancer
smoking cessation
hepatitis c virus
rectal cancer
hiv testing